A Study to Learn About the Study Medicine (Called ARV-471) in People With ER+/HER2- Advanced BC in China
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: ARV-471
Sponsor: Pfizer
Collaborators: Arvinas Estrogen Receptor, Inc.